Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Muscular weakness? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Muscular weakness have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.3% of all adverse event reports for MEDROXYPROGESTERONE.

26
Reports of Muscular weakness with MEDROXYPROGESTERONE
0.3%
of all MEDROXYPROGESTERONE reports
0
Deaths
5
Hospitalizations

How Dangerous Is Muscular weakness From MEDROXYPROGESTERONE?

Of the 26 reports, 5 (19.2%) required hospitalization, and 2 (7.7%) were considered life-threatening.

Is Muscular weakness Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Muscular weakness?

ADALIMUMAB (3,605) METHOTREXATE (2,813) RITUXIMAB (2,621) ATORVASTATIN (2,494) PREDNISONE (2,236) ETANERCEPT (2,207) DALFAMPRIDINE (1,916) TOCILIZUMAB (1,790) FINGOLIMOD (1,769) SECUKINUMAB (1,747)

Which MEDROXYPROGESTERONE Alternatives Have Lower Muscular weakness Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Muscular weakness Reports All Drugs Causing Muscular weakness MEDROXYPROGESTERONE Demographics